{"transactions":[{"id":4626772,"issuer":{"id":4374,"kind":"organization","name":"Pharvaris N.V.","symbol":"PHVS"},"owners":[{"id":41602,"kind":"person","name":"Monges Viviane","position":1,"cik":"0001838204","reported_name":"Monges Viviane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-25T17:35:55.000Z","date":"2026-09-23","kind":"exercise","planned":false,"acquired":false,"shares":11969,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter."}],"balance_after":9031,"derivative":{"exercise_price":8.05,"expiration_date":"2033-04-06","underlying":"Common Stock","underlying_shares":11969},"source":{"system":"sec-edgar","filing":"0001193125-26-402567","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1838204/000119312526402567/ownership.xml","form_type":"4"}},{"id":4626771,"issuer":{"id":4374,"kind":"organization","name":"Pharvaris N.V.","symbol":"PHVS"},"owners":[{"id":41602,"kind":"person","name":"Monges Viviane","position":1,"cik":"0001838204","reported_name":"Monges Viviane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-25T17:35:55.000Z","date":"2026-09-23","kind":"sale","planned":false,"acquired":false,"shares":11969,"price":33.0457,"value":395523.9833,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $33.00 to $33.0801. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":5500,"source":{"system":"sec-edgar","filing":"0001193125-26-402567","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1838204/000119312526402567/ownership.xml","form_type":"4"}},{"id":4626770,"issuer":{"id":4374,"kind":"organization","name":"Pharvaris N.V.","symbol":"PHVS"},"owners":[{"id":41602,"kind":"person","name":"Monges Viviane","position":1,"cik":"0001838204","reported_name":"Monges Viviane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-25T17:35:55.000Z","date":"2026-09-23","kind":"exercise","planned":false,"acquired":true,"shares":11969,"price":8.05,"value":96350.45,"ownership":{"direct":true},"balance_after":17469,"source":{"system":"sec-edgar","filing":"0001193125-26-402567","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1838204/000119312526402567/ownership.xml","form_type":"4"}},{"id":750715,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":41602,"kind":"person","name":"Monges Viviane","position":1,"cik":"0001838204","reported_name":"Monges Viviane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-06-03T21:03:03.000Z","date":"2026-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":2596,"price":3.08,"value":7995.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted."}],"balance_after":186447,"source":{"system":"sec-edgar","filing":"0001628280-26-040490","document":"wk-form4_1780520578.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000162828026040490/wk-form4_1780520578.xml","form_type":"4"}},{"id":750714,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":41602,"kind":"person","name":"Monges Viviane","position":1,"cik":"0001838204","reported_name":"Monges Viviane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-06-03T21:03:03.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of restricted stock units (\"RSUs\") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest on the earlier of (i) one year from the grant date or (ii) the date of the 2027 Annual Meeting of Shareholders, subject to the Reporting Person's continued service to the Issuer.  Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":189043,"source":{"system":"sec-edgar","filing":"0001628280-26-040490","document":"wk-form4_1780520578.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000162828026040490/wk-form4_1780520578.xml","form_type":"4"}},{"id":764835,"issuer":{"id":4374,"kind":"organization","name":"Pharvaris N.V.","symbol":"PHVS"},"owners":[{"id":41602,"kind":"person","name":"Monges Viviane","position":1,"cik":"0001838204","reported_name":"Monges Viviane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T21:53:25.000Z","date":"2026-05-21","kind":"sale","planned":false,"acquired":false,"shares":9667,"price":30.2941,"value":292853.0647,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The total number of shares beneficially owned previously reported in the Form 3 filed on March 18, 2026 was understated by 513 shares due to administrative errors in the number of shares reported as withheld for tax obligations in connection with RSU releases occurring on April 11, 2025 and March 12, 2026. This filing reflects the corrected beneficial ownership amount."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price represents a weighted average sale price for shares sold in multiple transactions at prices ranging from $30.08 to $30.49 per share. The shares sold were acquired upon vesting of restricted stock units on various dates. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":5500,"source":{"system":"sec-edgar","filing":"0001193125-26-239754","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830487/000119312526239754/ownership.xml","form_type":"4"}},{"id":1107280,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":41602,"kind":"person","name":"Monges Viviane","position":1,"cik":"0001838204","reported_name":"Monges Viviane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-17T21:02:50.000Z","date":"2025-06-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":2584,"price":3.58,"value":9250.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted."}],"balance_after":144043,"source":{"system":"sec-edgar","filing":"0001628280-25-031893","document":"wk-form4_1750194163.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000162828025031893/wk-form4_1750194163.xml","form_type":"4"}},{"id":1120845,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":41602,"kind":"person","name":"Monges Viviane","position":1,"cik":"0001838204","reported_name":"Monges Viviane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-05T21:07:08.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of restricted stock units (\"RSUs\") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest one year from the grant date, subject to the Reporting Person's\ncontinued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":146627,"source":{"system":"sec-edgar","filing":"0001628280-25-029729","document":"wk-form4_1749157579.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000162828025029729/wk-form4_1749157579.xml","form_type":"4"}},{"id":1474396,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":41602,"kind":"person","name":"Monges Viviane","position":1,"cik":"0001838204","reported_name":"Monges Viviane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-06-19T01:40:13.000Z","date":"2024-06-17","kind":"sale","planned":false,"acquired":false,"shares":1437,"price":2.89,"value":4152.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents Common Shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units."}],"balance_after":106627,"source":{"system":"sec-edgar","filing":"0001628280-24-028990","document":"wk-form4_1718761205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000162828024028990/wk-form4_1718761205.xml","form_type":"4"}},{"id":1478392,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":41602,"kind":"person","name":"Monges Viviane","position":1,"cik":"0001838204","reported_name":"Monges Viviane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-06-14T21:23:18.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of restricted stock units (\"RSUs\") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest one year from the grant date, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":108064,"source":{"system":"sec-edgar","filing":"0001628280-24-028339","document":"wk-form4_1718400187.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000162828024028339/wk-form4_1718400187.xml","form_type":"4"}},{"id":2671308,"issuer":{"id":5096,"kind":"organization","name":"DBV Technologies S.A."},"owners":[{"id":41602,"kind":"person","name":"Monges Viviane","position":1,"cik":"0001838204","reported_name":"Monges Viviane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2021-06-11T20:52:37.000Z","date":"2021-06-10","kind":"purchase","acquired":true,"shares":5000,"price":7.12,"value":35600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This price is in US Dollars and reflects the conversion of EUR to USD at an exchange rate of $1.2176 to EUR 1.00 as of June 10, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is in US Dollars and reflects the conversion of EUR to USD at an exchange rate of $1.2176 to EUR 1.00 as of June 10, 2021."}],"balance_after":5000,"derivative":{"exercise_price":13.09,"exercise_date":"2021-06-10","expiration_date":"2025-06-10","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-039884","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1613780/000120919121039884/doc4.xml","form_type":"4"}}]}